Skip to main content

Advertisement

Log in

A novel nanotechnological mucoadhesive and fast-dissolving film for vaginal delivery of clotrimazole: design, characterization, and in vitro antifungal action

  • Original Article
  • Published:
Drug Delivery and Translational Research Aims and scope Submit manuscript

Abstract

Pullulan (PUL) films containing pomegranate seed oil and Eudragit® RS100 nanocapsules loaded with clotrimazole (CTZ-NC-PUL) were developed to treat vulvovaginal candidiasis (VVC). Our findings showed that the nanocapsule average diameter was around 163 ± 4 nm, with polydispersity index values of up to 0.1 ± 0.01 and positively charged zeta potential (+ 43.5 ± 0.7 mV). The pH was in the acid range (5.14 ± 0.12) and encapsulation efficiency was around 99.6%; CTZ nanoencapsulation promoted higher homogeneity values for the film (91%), and the stability studies displayed no changes in the drug content after 120 days for the CTZ-NC-PUL under refrigerated conditions. All formulations were considered non-irritant, and CTZ-NC-PUL promoted a controlled release of the drug (60% in 24 h) compared to CTZ-PUL (100% in 8 h). The permeation results corroborate the drug release, where higher CTZ amounts were found in the mucosa and receptor medium for CTZ-PUL (21.02 and 4.46 μg/cm2). The films were fast dissolving (10 min), and CTZ-NC-PUL presented higher mucoadhesive properties; the antifungal activity against Candida albicans was maintained, and the in vitro efficacy of the film was proved. In conclusion, CTZ-NC-PUL formulation was considered promising and suitable for vaginal application against candida-related infections.

Graphical abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Data availability

Not applicable.

References

  1. Chatzivasileiou P, Vyzantiadis TA. Vaginal yeast colonisation: from a potential harmless condition to clinical implications and management approaches-a literature review. Mycoses, 2019:62:638–50. Available from: https://pubmed.ncbi.nlm.nih.gov/31038771/.

  2. Qais FA, Khan MSA, Ahmad I, Althubiani AS. Potential of nanoparticles in combating candida infections. Letters in Drug Design & Discovery. Bentham Science Publishers Ltd.; 2018;16:478–91.

  3. Achkar JM, Fries BC. Candida infections of the genitourinary tract. Clinical Microbiology Reviews. American Society for Microbiology (ASM); 2010;23:253. Available from: https://doi.org/10.1128/CMR.00076-09.

  4. Nel AM, Mitchnick LB, Risha P, Muungo LTM, Norick PM. Acceptability of vaginal film, soft-gel capsule, and tablet as potential microbicide delivery methods among African women. Journal of women’s health (2002) [Internet]. J Womens Health (Larchmt). 2011;20:1207–14. Available from: https://pubmed.ncbi.nlm.nih.gov/21774672/.

  5. Zhou X, Li T, Fan S, Zhu Y, Liu X, Guo X, et al. The efficacy and safety of clotrimazole vaginal tablet vs. oral fluconazole in treating severe vulvovaginal candidiasis. Mycoses. Blackwell Publishing Ltd. 2016;59:419–28.

  6. de Lima JA, Paines TC, Motta MH, Weber WB, dos Santos SS, Cruz L, et al. Novel Pemulen/Pullulan blended hydrogel containing clotrimazole-loaded cationic nanocapsules: evaluation of mucoadhesion and vaginal permeation. Materials science & engineering C, Materials for biological applications. Mater Sci Eng C Mater Biol Appl. 2017;79:886–93. Available from: https://pubmed.ncbi.nlm.nih.gov/28629093/.

  7. Bunge KE, Dezzutti CS, Rohan LC, Hendrix CW, Marzinke MA, Richardson-Harman N, et al. A Phase 1 trial to assess the safety, acceptability, pharmacokinetics and pharmacodynamics of a novel dapivirine vaginal film. J Acquir Immune Defic Syndr. (1999). NIH Public Access; 2016;71:498. Available from: https://doi.org/10.1097/QAI.0000000000000897.

  8. Leyva-Gómez G, Piñón-Segundo E, Mendoza-Muñoz N, Zambrano-Zaragoza ML, Mendoza-Elvira S, Quintanar-Guerrero D. Approaches in polymeric nanoparticles for vaginal drug delivery: a review of the state of the art. International journal of molecular sciences. Int J Mol Sci. 2018;19. Available from: https://pubmed.ncbi.nlm.nih.gov/29882846/.

  9. Martínez-Pérez B, Quintanar-Guerrero D, Tapia-Tapia M, Cisneros-Tamayo R, Zambrano-Zaragoza ML, Alcalá-Alcalá S, et al. Controlled-release biodegradable nanoparticles: from preparation to vaginal applications. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences. Eur J Pharm Sci. 2018;115:185–95. Available from: https://pubmed.ncbi.nlm.nih.gov/29208486/.

  10. Jain AK, Thareja S. In vitro and in vivo characterization of pharmaceutical nanocarriers used for drug delivery. Artificial cells, nanomedicine, and biotechnology. Artif Cells Nanomed Biotechnol. 2019;47:524–39. Available from: https://pubmed.ncbi.nlm.nih.gov/30784319/.

  11. Santos SS, Lorenzoni A, Ferreira LM, Mattiazzi J, Adams AIH, Denardi LB, et al. Clotrimazole-loaded Eudragit® RS100 nanocapsules: preparation, characterization and in vitro evaluation of antifungal activity against Candida species. Mater Sci Eng C Mater Biol Appl; 2013;33:1389–94. Available from: https://pubmed.ncbi.nlm.nih.gov/23827586/.

  12. Santos SS, Lorenzoni A, Pegoraro NS, Denardi LB, Alves SH, Schaffazick SR, et al. Formulation and in vitro evaluation of coconut oil-core cationic nanocapsules intended for vaginal delivery of clotrimazole. Colloids Surf B Biointerfaces. 2014;116:270–6. Available from: https://pubmed.ncbi.nlm.nih.gov/24503350/.

  13. Morales JO, McConville JT. Manufacture and characterization of mucoadhesive buccal films. European J Pharmaceut Biopharmaceut. Elsevier. 2011;77:187–99.

  14. Karki S, Kim H, Na SJ, Shin D, Jo K, Lee J. Thin films as an emerging platform for drug delivery. Asian J Pharmaceut Sci Elsevier. 2016;11:559–74.

    Google Scholar 

  15. Ferrari Cervi V, Parcianello Saccol C, Henrique Marcondes Sari M, Cristóvão Martins C, Saldanha da Rosa L, Dias Ilha B, et al. Pullulan film incorporated with nanocapsules improves pomegranate seed oil anti-inflammatory and antioxidant effects in the treatment of atopic dermatitis in mice. Internatl J Pharmaceut. Elsevier. 2021;609:121144.

  16. Palmeira-de-Oliveira R, Monteiro Machado R, Martinez-de-Oliveira J, Palmeira-de-Oliveira A. Testing vaginal irritation with the Hen’s Egg Test-chorioallantoic membrane assay. ALTEX. 2018;35:495–503. Available from: https://pubmed.ncbi.nlm.nih.gov/29534246/.

  17. Rezaee F, Ganji F. Formulation, characterization, and optimization of captopril fast-dissolving oral films. AAPS Pharm Sci Tech.  2018 19:5. Springer; 2018;19:2203–12. Available from: https://doi.org/10.1208/s12249-018-1027-y.

  18. das Neves J, Amaral MH, Bahia MF. Performance of an in vitro mucoadhesion testing method for vaginal semisolids: influence of different testing conditions and instrumental parameters. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik eV. Eur J Pharm Biopharm; 2008;69:622–32. Available from: https://pubmed.ncbi.nlm.nih.gov/18248972/.

  19. Nielsen LS, Schubert L, Hansen J. Bioadhesive drug delivery systems. I. Characterisation of mucoadhesive properties of systems based on glyceryl mono-oleate and glyceryl monolinoleate. European J Pharmaceut Sci. 1998;6:231–9.

  20. Takeuchi H, Thongborisute J, Matsui Y, Sugihara H, Yamamoto H, Kawashima Y. Novel mucoadhesion tests for polymers and polymer-coated particles to design optimal mucoadhesive drug delivery systems. Adv Drug Deliv Rev; 2005;57:1583–94. Available from: https://pubmed.ncbi.nlm.nih.gov/16169120/.

  21. Kalyanwat R, Shrivastava B, Pathak K. preparation and evaluation of bioadhesive ocular inserts of aceclofenac. Int J Pharm Sci Rev Res. 2016;41:207–13. Available from: https://www.researchgate.net/publication/312023461_Preparation_and_Evaluation_of_bioadhesive_ocular_inserts_of_aceclofenac.

  22. Ferreira LM, Cervi VF, Gehrcke M, da Silveira EF, Azambuja JH, Braganhol E, et al. Ketoprofen-loaded pomegranate seed oil nanoemulsion stabilized by pullulan: selective antiglioma formulation for intravenous administration. Colloids Surf B Biointerfaces. 2015;130:272–7. Available from: https://pubmed.ncbi.nlm.nih.gov/25935266/.

  23. Li H, Li J, Bodycomb J, Patience GS. Experimental methods in chemical engineering: particle size distribution by laser diffraction—PSD. The Canadian Journal of Chemical Engineering. John Wiley & Sons, Ltd; 2019;97:1974–81. Available from: https://doi.org/10.1002/cjce.23480.

  24. Venturini CG, Bruinsmann FA, Oliveira CP, Contri RV, Pohlmann AR, Guterres SS. Vegetable oil-loaded nanocapsules: innovative alternative for incorporating drugs for parenteral administration. J Nanosci Nanotechnol. 2016;16:1310–20. Available from: https://pubmed.ncbi.nlm.nih.gov/27433581/.

  25. Palmeira-de-Oliveira R, Palmeira-de-Oliveira A, Martinez-de-Oliveira J. New strategies for local treatment of vaginal infections. Adv Drug Deliv Rev. 2015;92:105–22. Available from: https://pubmed.ncbi.nlm.nih.gov/26144995/.

  26. Nair AB, Kumria R, Harsha S, Attimarad M, Al-Dhubiab BE, Alhaider IA. In vitro techniques to evaluate buccal films. Journal of controlled release : official journal of the Controlled Release Society. J Control Release, 2013;166:10–21. Available from: https://pubmed.ncbi.nlm.nih.gov/23219961/.

  27. Dixit RP, Puthli SP. Oral strip technology: overview and future potential. J Control Release Elsevier. 2009;139:94–107.

    Article  CAS  Google Scholar 

  28. Kola R, Pragathi Kumar B. A detailed description of synthetic and natural polymers which are used in the formulation of sustained release drug delivery system: a review. 2021. Available from: www.jchps.com.

  29. Stability of drugs and dosage forms. stability of drugs and dosage forms. Kluwer Academic Publishers; 2002.

  30. Borges AF, Silva C, Coelho JFJ, Simões S. Oral films: Current status and future perspectives: I - galenical development and quality attributes. Journal of controlled release : official journal of the Controlled Release Society. J Control Release, 2015;206:1–19. Available from: https://pubmed.ncbi.nlm.nih.gov/25747406/.

  31. Mansuri S, Kesharwani P, Jain K, Tekade RK, Jain NK. Mucoadhesion: a promising approach in drug delivery system. Reactive Function Polym Elsevier. 2016;100:151–72.

    Article  CAS  Google Scholar 

  32. Andrews GP, Laverty TP, Jones DS. Mucoadhesive polymeric platforms for controlled drug delivery. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik eV. Eur J Pharm Biopharm. 2009;71:505–18. Available from: https://pubmed.ncbi.nlm.nih.gov/18984051/.

  33. Chaves PDS, Frank LA, Frank AG, Pohlmann AR, Guterres SS, Beck RCR. Mucoadhesive properties of Eudragit®RS100, Eudragit®S100, and Poly(ε-caprolactone) nanocapsules: influence of the vehicle and the mucosal surface. AAPS Pharm Sci Tech. 2018;19:1637–46. Available from: https://pubmed.ncbi.nlm.nih.gov/29500762/.

  34. Malgarim Cordenonsi L, Faccendini A, Catanzaro M, Bonferoni MC, Rossi S, Malavasi L, et al. The role of chitosan as coating material for nanostructured lipid carriers for skin delivery of fucoxanthin. Int J Pharm; 2019;567. Available from: https://pubmed.ncbi.nlm.nih.gov/31271813/.

  35. Baloglu E, Senyigit ZA, Karavana SY, Bernkop-Schnürch A. Strategies to prolong the intravaginal residence time of drug delivery systems. Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques. J Pharm Pharm Sci; 2009;12:312–36. Available from: https://pubmed.ncbi.nlm.nih.gov/20067707/.

  36. Friend DR. Pharmaceutical development of microbicide drug products. Pharm Dev Technol; 2010;15:562–81. Available from: https://pubmed.ncbi.nlm.nih.gov/20017601/.

  37. Cunha-Reis C, Machado A, Barreiros L, Araújo F, Nunes R, Seabra V, et al. Nanoparticles-in-film for the combined vaginal delivery of anti-HIV microbicide drugs. Journal of controlled release : official journal of the Controlled Release Society. J Control Release 2016;243:43–53. Available from: https://pubmed.ncbi.nlm.nih.gov/27664327/.

  38. Cautela MP, Moshe H, Sosnik A, Sarmento B, das Neves J. Composite films for vaginal delivery of tenofovir disoproxil fumarate and emtricitabine. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik eV. Eur J Pharm Biopharm; 2019;138:3–10. Available from: https://pubmed.ncbi.nlm.nih.gov/29408341/.

  39. Garg S, Goldman D, Krumme M, Rohan LC, Smoot S, Friend DR. Advances in development, scale-up and manufacturing of microbicide gels, films, and tablets. Antiviral research. Antiviral Res; 2010;88 Suppl 1. Available from: https://pubmed.ncbi.nlm.nih.gov/21109064/.

  40. Englert AV, Verdi CM, Santos RCV, Cruz L, Sari MHM. Diphenyl diselenide and clotrimazole co-loaded into Eudragit® RS 100 nanocapsules formulation has superior antioxidant potential and promising anti-candida activity. Brazilian Arch Biol Technol. 2020;63.

Download references

Acknowledgements

We gratefully acknowledge UFSM and Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES-BR) and CNPq. We also would like to thank C.B. Silva for zetasizer access and Charlene Menezes for Zetasizer and Mastersizer analysis. We would also like to thank Atlas Assessoria Linguística for language editing.

Funding

Verônica Ferrari Cervi was granted a Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES-BR) master’s fellowship (process number: 88882.427737/2019–01). Letícia Cruz for received PQ fellowship from CNPq (process number: 315612/2020–7).

Author information

Authors and Affiliations

Authors

Contributions

All authors substantially contributed to developing this study by discussing, interpreting, reviewing, and commenting on the results. All authors approved the final version of this manuscript. Additionally, each author provided specific contributions: Verônica Ferrari Cervi: methodology, data curation, formal analysis, investigation, writing—original draft, writing—review & editing, visualization, conceptualization; Camila Parcianello Saccol: methodology, data curation, investigation, writing—review & editing; Ticiane da Rosa Pinheiro: methodology, data curation, conceptualization, writing—review & editing; Roberto Christ Viana Santos: methodology, conceptualization; writing—review & editing; Marcel Henrique Marcondes Sari: methodology, data curation, investigation, visualization, conceptualization, writing—review & editing; Letícia Cruz: conceptualization, methodology, writing—original draft, writing—review & editing, supervision, funding acquisition.

Corresponding author

Correspondence to Letícia Cruz.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 234 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cervi, V.F., Saccol, C.P., da Rosa Pinheiro, T. et al. A novel nanotechnological mucoadhesive and fast-dissolving film for vaginal delivery of clotrimazole: design, characterization, and in vitro antifungal action. Drug Deliv. and Transl. Res. 12, 2907–2919 (2022). https://doi.org/10.1007/s13346-022-01154-1

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13346-022-01154-1

Keywords

Navigation